“a decreasing trend”

Moreover, an immunofluorescence staining assay revealed a decreasing trend in the proportion of slow myofibers and an increase in fast myofibers in mice treated with BBE ( p < 0.01 for BBE50 and BBE100 in slow and fast myofibers) ( Figure 4 E,F).

Compared with the LPS group, the lung index of the OS and DXM groups showed a decreasing trend ( P <0.01), while the lung index of the OS and DXM groups also showed an increase compared with the NS group (P <0.05).

The HBsAg positive rate among pregnant women decreased from 5.23% in 2015 to 3.47% in 2022, thus showing a decreasing trend over time ( χ 2 trend = 84.588, P < 0.01) (see Table 2 ; Fig. 2 A).

50 We observed a reduction of 3-hydroxybutyrate concentration ( P -value = 3 × 10 –5 and FDR = 0.0043) in patients with the PFO; there are also a decreasing trend for glucose ( P -value = 0.0101 and FDR = 0.0683) and an increase of acetone ( P -value = 0.0007 and FDR = 0.0129) which are, however, not significant after adjustment.

For men, there was a decreasing trend in AAMR from 1999 to 2012 (APC -0.98, 95 %CI: −1.31 to −0.69) (p value = 0.010398).

The results showed that compared with the CON group, the TPA indicators in the AFB1 group showed a decreasing trend of hardness, springiness, gumminess, chewiness, and resilience in the breast muscle ( p = 0.011, 0.135, 0.291, 0.585, and 0.009, respectively).

3E ) presents a decreasing trend, similar to GST response in the midgut, especially with N. ceranae infection (ANOVA, N = 43, F = 4.238, p – value = 0.011; Tukey post-hoc test at 95% confidence level, C vs.

However, there was a difference in the pre-PDSA cycles, with the opioid stewardship programme hospital presenting higher inpatient opioid consumption (average of 16 mg oral morphine equivalents higher; 95% CI 5 to 27; p=0.008) but a decreasing trend of −2 mg oral morphine equivalents per month (95% CI −4 to –0.6; p=0.011) compared with the control hospital.

However, a decreasing trend in 100‐day mortality was observed, with improved DSS over the study period (1988–2002 compared with 2003–2017, p = 0.011), despite increased median age at PTLD diagnosis.

Prescriptions for boys aged 19–24 years were associated with a minor portion and exhibited a decreasing trend ( P = 0.011).

A decreasing trend was shown in NHB ( P = 0.011) from 2006 to 2016.

pneumoniae , the resistance rate to imipenem and meropenem significantly increased in 2019 ( p < 0.05), while that to cefoperazone/sulbactam showed a decreasing trend during the study period ( p = 0.0110) ( Figure 4 C).

Additionally, with each year increase in patients’ age, their costs have shown a decreasing trend ( p value = 0.011) (Table 4 ). 3.4.

With an increasing MCCA grade, age (61.9±14.0, 68.2±13.8, and 76.4±9.4 years for grades 1, 2, and 3, respectively, p=0.005) and proportion of female (p<0.001) had an increasing trend, whereas cervical lordosis had a decreasing trend (11.7±13.5°, 7.0±14.5°, and −10.0±19.2° for grades 1, 2, and 3, respectively, p=0.011).

There was a decreasing trend in the age at admission for DD ( p = 0.011) and an increasing trend for BD ( p = 0.001).

Positive rates of epithelial Cav-1 in gastritis without IM, gastritis with IM and GC showed a decreasing trend ( P = 0.012).

Additionally, Zhao et al ( 35 ) found that positive rates of epithelial Cav-1 expression in gastritis without intestinal metaplasia (IM), gastritis with IM and GC showed a decreasing trend compared with gastritis without IM, gastritis with IM and GC (P=0.012).

Waist circumference showed a decreasing trend from Q1 to Q4 (102.03 ± 14.48 cm to 100.22 ± 15.99 cm; P = 0.012), while BMI remained comparable across quartiles ( P = 0.860).

The prevalence of NAFLD exhibited a decreasing trend with the rise in the PRL quartile in both sexes (T1: 84.2%, T2: 63.8%, T3: 59.6%, T4: 58.6%, p=0.012 in men; T1: 79.5%, T2: 65.9%, T3: 54.5%, T4: 50%, p=0.013 in women).

1, the min longitude of JE emerging townships displayed a decreasing trend of 0.007 per month ( P = 0.034), while the max latitude of JE emerging townships exhibited an increasing trend of 0.009 per month ( P = 0.012).

An increasing trend was observed in the incidence of BK ( P = 0.001) and graft failure ( P = 0.025) over the study period; however, the rate of COS showed a decreasing trend ( P = 0.012).

TRAb levels showed a decreasing trend, albeit not statistically significant (Cohen’s d = 0.71, p = 0.012) (Table 4 ).

Hippocampal WB analysis ( Figure 3A ) revealed significant age-dependent upregulation of cuproptosis regulators in 18M+WT mice versus young controls: FDX1 increased [One-way ANOVA: F (2, 13) = 8.739, p = 0.0039; Figures 3B,C ]; LIAS increased [One-way ANOVA: F (2, 13) = 10.95, p = 0.0016; Figures 3B,D ]; DLAT showed a decreasing trend [One-way ANOVA: F (2, 13) = 6.248, p = 0.01225; Figures 3B,E ].

Estimating the effect of ALD, NAFLD, and potential mediators on BMD As shown in Fig 2 , genetically determined ALD was significantly associated with a decreasing trend of FN-BMD at the Bonferroni corrected significance of P < 0.0125 (IVW beta = -0.0288; 95% CI: -0.0488, -0.00871; P = 0.00494).

A structured and supervised program lasting 6 weeks, which included body-awareness training, massages, relaxation techniques, and resistance and fitness training, showed a decreasing trend in myalgia ( p = 0.013) and pain ( p = 0.013) levels within 6 weeks [ 34 ], as well as in peripheral neuropathy immediately after the intervention ( p = 0.028) and at 4 weeks ( p = 0.031) [ 77 ].